Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2025 ,inter alia, to consider and approve The Audited Standalone and Consolidated Financial statements and Financial results of the Company for the quarter and year ended March 31, 2025 and 2. Any other business with the permission of Chair.
Board Meeting Intimation for The Quarter And Financial Year Ended March 31, 2025.
On 6ix: 6ix.com/news/board-meeting-intimation-for-the-quarter-and-financial-year-ended-march-31-2025
View original source (BSE India)Vivanza Biosciences Ltd. on 6ix
Story so far
Earlier from Vivanza Biosciences
- Vivanza Biosciences Ltd. Press Release May 02 2025
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Vivanza Biosciences Ltd. Press Release Apr 11 2025
- Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
- Vivanza Biosciences Ltd. Press Release Apr 03 2025
Later from Vivanza Biosciences
- Board Meeting Outcome for Outcome Of Board Meeting Held Today 12Th May, 2025
- Audited Financial Result For The Quarter And Financial Year Ended On 31St March, 2025
- Announcement under Regulation 30 (LODR)-Change in Management
- Vivanza Biosciences Ltd. Press Release May 12 2025
- Newspaper Publication
Follow Vivanza Biosciences into a list and get an email when it puts out news.
Follow Vivanza Biosciences